Rivista
/
/
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
JoVE Journal
Ricerca sul cancro
È necessario avere un abbonamento a JoVE per visualizzare questo.  Accedi o inizia la tua prova gratuita.
JoVE Journal Ricerca sul cancro
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
DOI:

12:42 min

January 07, 2019

,

Capitoli

  • 00:04Titolo
  • 00:47Generation of Recombinant Virus Particles
  • 02:47Collection and Propagation of Virus Particles
  • 05:11Viral Titer Evaluation
  • 06:59Determining Replicative and Cytotoxic Capacities of Viral Vectors Encoding Immunomodulators
  • 08:03Assessment of Immunological Functionality of Isolated Virus-encoded Immunomodulators from Infected Cells
  • 10:00Results: Evaluation of Tumor-targeted Immunomodulation by Paramyxoviruses
  • 11:37Conclusion

Summary

Traduzione automatica

This protocol describes a detailed workflow for the generation and ex vivo characterization of oncolytic viruses for expression of immunomodulators, using measles viruses encoding bispecific T cell engagers as an example. Application and adaptation to other vector platforms and transgenes will accelerate the development of novel immunovirotherapeutics for clinical translation.

Video correlati

Read Article